Literature DB >> 18177256

Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002).

Yutaka Aoki1, Ruth M Belin, Robert Clickner, Rebecca Jeffries, Linda Phillips, Kathryn R Mahaffey.   

Abstract

OBJECTIVE: Describe thyrotropin (TSH) and thyroxine (T4) levels in the U.S. population and their association with selected participant characteristics.
DESIGN: Secondary analysis of data from the National Health and Nutrition Examination Survey (NHANES) collected from 4392 participants, reflecting 222 million individuals, during 1999-2002.
RESULTS: Hypothyroidism prevalence (TSH > 4.5 mIU/L) in the general population was 3.7%, and hyperthyroidism prevalence (TSH < 0.1 mIU/L) was 0.5%. Among women of reproductive age (12-49 years), hypothyroidism prevalence was 3.1%. Individuals aged 80 years and older had five times greater odds for hypothyroidism compared to 12- to 49-year-olds (adjusted odds ratio [OR] = 5.0, p = 0.0002). ORs were adjusted for sex, race, annual income, pregnancy status, and usage of thyroid-related medications (levothyroxine/thyroid, estrogen, androgen, lithium, and amiodarone). Compared to non-Hispanic whites, non-Hispanic blacks had a lower risk for hypothyroidism (OR = 0.46, p = 0.04) and a higher risk for hyperthyroidism (OR = 3.18, p = 0.0005), while Mexican Americans had the same risk as non-Hispanic whites for hypothyroidism, but a higher risk for hyperthyroidism (OR = 1.98, p = 0.04). Among those taking levothyroxine or desiccated thyroid, the adjusted risk for either hypothyroidism (OR = 4.0, p = 0.0001) or hyperthyroidism (OR = 11.4, p = 4 x 10(-9)) was elevated.
CONCLUSIONS: Associations with known factors such as age, race, and sex were confirmed using this data set. Understanding the prevalence of abnormal thyroid tests among reproductive-aged women informs decisions about screening in this population. The finding that individuals on thyroid hormone replacement medication often remain hypothyroid or become hyperthyroid underscores the importance of monitoring.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18177256     DOI: 10.1089/thy.2006.0235

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  111 in total

1.  Levothyroxine absorption in morbidly obese patients before and after Roux-En-Y gastric bypass (RYGB) surgery.

Authors:  Ileana Gabriela Sanchez Rubio; Ana Luiza Galrão; Marco Aurelio Santo; Antonio Carlos Zanini; Geraldo Medeiros-Neto
Journal:  Obes Surg       Date:  2012-02       Impact factor: 4.129

2.  Repression of cardiac phospholamban gene expression is mediated by thyroid hormone receptor-{alpha}1 and involves targeted covalent histone modifications.

Authors:  Madesh Belakavadi; Jason Saunders; Noah Weisleder; Preethi S Raghava; Joseph D Fondell
Journal:  Endocrinology       Date:  2010-04-14       Impact factor: 4.736

Review 3.  Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.

Authors:  Richard A Spritz
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

Review 4.  Influence of maternal thyroid hormones during gestation on fetal brain development.

Authors:  N K Moog; S Entringer; C Heim; P D Wadhwa; N Kathmann; C Buss
Journal:  Neuroscience       Date:  2015-10-03       Impact factor: 3.590

Review 5.  Evidence needed to inform the next dietary reference intakes for iodine.

Authors:  Paula R Trumbo
Journal:  Adv Nutr       Date:  2013-11-06       Impact factor: 8.701

6.  An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction.

Authors:  Sarah J Peterson; Anne R Cappola; M Regina Castro; Colin M Dayan; Alan P Farwell; James V Hennessey; Peter A Kopp; Douglas S Ross; Mary H Samuels; Anna M Sawka; Peter N Taylor; Jacqueline Jonklaas; Antonio C Bianco
Journal:  Thyroid       Date:  2018-04-05       Impact factor: 6.568

7.  Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines.

Authors:  Wendy Landier; Saro H Armenian; Jin Lee; Ola Thomas; F Lennie Wong; Liton Francisco; Claudia Herrera; Clare Kasper; Karla D Wilson; Meghan Zomorodi; Smita Bhatia
Journal:  J Clin Oncol       Date:  2012-10-22       Impact factor: 44.544

8.  Effect of thyroid peroxidase antibodies on thyroid-stimulating hormone reference limits in a primarily Latina population.

Authors:  Richard H Lee; Carole A Spencer; Martin N Montoro; Paola Aghajanian; T Murphy Goodwin; Erin A Miller; Ivana Petrovic; Lewis E Braverman; Jorge H Mestman
Journal:  Obstet Med       Date:  2009-11-30

9.  Subclinical hypothyroidism and risk for incident myocardial infarction among postmenopausal women.

Authors:  Vicky A LeGrys; Michele Jonsson Funk; Carol E Lorenz; Ayush Giri; Rebecca D Jackson; JoAnn E Manson; Robin Schectman; Todd L Edwards; Gerardo Heiss; Katherine E Hartmann
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

Review 10.  Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes.

Authors:  Mark D Miller; Kevin M Crofton; Deborah C Rice; R Thomas Zoeller
Journal:  Environ Health Perspect       Date:  2009-02-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.